Sona Nanotech Receives ‘Deprioritization’ from FDA; Health Canada Evaluation Continues

You may also like

Sona Provides Update on First-In-Human Clinical Trial

Sona Announces Canadian Melanoma Clinical ‘Pilot’ Study Ethics Approval

First Patient Dosed in Early Feasibility Study Trial of Its Cancer Therapy

Sona Announces Ethics Committee Approval For Melanoma Clinical Trial